Target discovery for T cell therapy: next steps to advance Immunotherapies
نویسندگان
چکیده
Investigators from academia and industry gathered on August 14, 2014, in Boston at the Inaugural ImVacS conference entitled “Target Discovery for T Cell Therapy: Next Step to Advance Immunotherapies”. Novel targets, discovery strategies and enabling technologies were presented and discussed.
منابع مشابه
Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells
CRISPR (clustered, regularly interspaced, short palindromic repeats)/Cas9 (CRISPR-associated protein 9) has become the tool of choice for generating gene knockouts across a variety of species. The ability for efficient gene editing in primary T cells not only represents a valuable research tool to study gene function but also holds great promise for T cell-based immunotherapies, such as next-ge...
متن کاملCAR T-cell Therapy of Hematologic Malignancies: An Update in Targeted Antigens
Immunotherapy with genetically engineered T-cells that express the chimeric antigen receptor (CAR) has raised hopes for the treatment of pediatric malignancies. Although CAR T-cell development is on a fast-moving pace and evolution, the context of exploring novel targetable antigens has been neglected. In this review study, we analyze the prominent hematologic antigens targeted by engineered T-...
متن کاملAssessment of The Relation Between Energy Of Primary Protons And Undesired Neutron Dose During Proton Therapy By Monte Carlo Method
Introduction: High-energy beams of protons offer significant advantages for the treatment of deepseated local tumors. Their physical depth-dose distribution in tissue is characterized by a small entrance dose and a distinct maximum -Bragg peak- near the end of range with a sharp fall-off at the distal edge. Alongside its advantages there are some point that they need to meticul...
متن کاملPreclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy
Background Preclinical safety testing for adoptive immunotherapies utilising T cell receptor-(TCR) engineered T cells relies on stringent target validation and a robust pre-clinical specificity testing strategy. Specific safety concerns include ontarget off-tumour toxicity and off-target toxicity. Avoidance of these toxicities requires that the expression profile of the target antigen be shown ...
متن کاملImmunotherapy in kidney cancer: the past, present, and future.
PURPOSE OF REVIEW Kidney cancer, in particular clear cell renal cell carcinoma (ccRCC) has long been considered to be sensitive to immunotherapies. With the recent breakthroughs in immunotherapy for solid tumors and the recent approval of the first immune checkpoint inhibitor for ccRCC, we are reviewing the history of immunotherapy in kidney cancer, describing its current state and look into th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 3 شماره
صفحات -
تاریخ انتشار 2015